Table 1

Demographics and clinical outcomes between the off-hour group and the on-hour group

VariableDefined off-hour with arrival time (arrival mode)P valueDefined off-hour with groin-puncture time (puncture mode)P value
Off-hour n=435On-hour n=263Off-hour n=456On-hour n=242
Age, year, median (IQR)65.0 (57.0–73.0)66.0 (56.0–75.0)0.58765.0 (57.0–73.0)66.0 (56.0–75.0)0.831
Male, n (%)282 (64.8)141 (53.6)0.003285 (62.5)138 (57.0)0.159
SBP, mm Hg, median (IQR)145.0 (130.0–160.0)146.0 (129.0–160.0)0.624145.0 (130.0–160.8)145.0 (127.5–160.0)0.474
DBP, mm Hg, median (IQR)82.0 (76.0–92.0)83.0 (74.0–93.0)0.69783.0 (76.0–92.0)80.0 (72.0–93.0)0.079
Glucose, mmol/L, median (IQR)6.8 (5.8–8.6)6.5 (5.5–8.6)0.0826.8 (5.8–8.6)6.4 (5.5–8.4)0.024
Medical history, n (%)
 Atrial fibrillation177 (40.7)111 (42.2)0.693189 (41.4)99 (40.9)0.891
 Hypertension278 (63.9)164 (62.4)0.680290 (63.6)152 (62.8)0.837
 Diabetes80 (18.4)48 (18.3)0.96385 (18.6)43 (17.8)0.777
Current smoking, n (%)123 (28.3)61 (23.2)0.140131 (28.7)53 (21.9)0.051
ASPECTS, median (IQR)9.0 (8.0–10.0)9.0 (8.0–10.0)0.9329.0 (8.0–10.0)9.0 (8.0–10.0)0.925
Baseline NIHSS, median (IQR)16.0 (12.0–20.0)17.0 (12.0–21.0)0.15416.0 (12.0–20.0)17.0 (12.0–21.0)0.071
Intravenous thrombolysis, n (%)153 (35.2)76 (28.9)0.087158 (34.6)71 (29.3)0.155
Local anaesthesia, n (%)358 (82.3)202 (76.8)0.077373 (81.8)187 (77.3)0.153
Stroke aetiology, n (%)0.6690.950
 LAA191 (43.9)118 (44.9)202 (44.3)107 (44.2)
 CE216 (49.7)124 (47.1)223 (48.9)117 (48.3)
 Others28 (6.4)21 (8.0)31 (6.8)18 (7.4)
ICA occlusion, n (%)174 (40.0)107 (40.7)0.858187 (41.0)94 (38.8)0.579
MCA occlusion, n (%)257 (59.1)154 (58.6)0.891264 (57.9)147 (60.7)0.467
ASITN/SIR 0–1, n (%)221 (50.8)117 (44.5)0.106226 (49.6)112 (46.3)0.409
Onset to door, min, median (IQR)120.0 (60.0–212.0)140.0 (64.0–240.0)0.047125.0 (60.0–220.0)127.0 (63.5–232.5)0.542
Door to imaging, min, median (IQR)23.0 (12.0–33.0)24.0 (13.0–32.0)0.94023.0 (12.0–34.0)24.0 (15.0–32.0)0.885
Door to puncture, min, median (IQR)128.0 (84.0–177.0)125.0 (80.0–172.0)0.597130.0 (86.3–177.0)120.0 (75.0–165.0)0.161
Puncture to reperfusion, min, median (IQR)100.0 (72.0–145.0)101.0 (77.0–138.0)0.85899.5 (70.0–140.8)103.0 (79.8–143.5)0.235
Onset to puncture, min, median (IQR)266.0 (201.0–345.0)285.0 (210.0–360.0)0.098273.5 (204.3–349.5)270.5 (210.0–360.0)0.711
Onset to reperfusion, min, median (IQR)380.0 (299.0–470.0)383.0 (310.0–488.0)0.393382.0 (299.0–470.0)380.5 (313.0–488.5)0.656
Successful reperfusion, n (%)361 (83.0)218 (82.9)0.973378 (82.9)201 (83.1)0.957
Symptomatic ICH, n (%)69 (15.9)39 (14.8)0.71574 (16.2)34 (14.0)0.449
Asymptomatic ICH, n (%)140 (32.2)78 (29.7)0.485144 (31.6)74 (30.6)0.786
Mortality in hospital, n (%)104 (23.9)59 (22.4)0.655110 (24.1)53 (21.9)0.509
mRS score at 90 days, median (IQR)3 (1–6)3 (1–6)0.6243 (1–6)3 (2–6)0.549
Favourable outcome, n (%)190 (43.7)114 (43.3)0.932200 (43.9)104 (43.0)0.823
Mortality at 90 days, n (%)109 (25.1)68 (25.9)0.814116 (25.4)61 (25.2)0.947
  • ASITN/SIR, American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology; ASPECTS, Alberta Stroke Program Early CT Score; CE, cardioembolism; DBP, diastolic blood pressure; ICA, intracranial artery; ICH, intracranial haemorrhage; LAA, large-artery atherosclerosis; MCA, middle cerebral artery; mRS, modified Rankin Scale; NIHSS, National Institute of Health Stroke Scale; SBP, systolic blood pressure.